• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Therapeuticsmd Inc (NQ: TXMD )

    1.800 +0.100 (+5.88%)
    Streaming Delayed Price Updated: 11:06 AM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,312
    Open 1.790
    Bid (Size) 1.750 (3)
    Ask (Size) 1.780 (2)
    Prev. Close 1.700
    Today's Range 1.755 - 1.841
    52wk Range 1.430 - 4.350
    Shares Outstanding 9,953,290
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023
    TherapeuticsMD just reported results for the fourth quarter of 2023. 
    Via InvestorPlace
    TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
    TherapeuticsMD just reported results for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -22.75%
    -22.75%
    1 Month
    -13.47%
    -13.47%
    3 Month
    -16.67%
    -16.67%
    6 Month
    -23.73%
    -23.73%
    1 Year
    -54.43%
    -54.43%

    More News

    Read More
    TherapeuticsMD Announces First Quarter 2024 Financial Results
    From TherapeuticsMD, Inc.
    Via Business Wire
    TherapeuticsMD Announces Full Year 2023 Financial Results
    From TherapeuticsMD, Inc.
    Via Business Wire
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    TherapeuticsMD Announces Third Quarter 2023 Financial Results
    From TherapeuticsMD, Inc.
    Via Business Wire
    Nasdaq Jumps 100 Points; US Trade Deficit Widens In September
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    TherapeuticsMD Announces Second Quarter 2023 Financial Results
    From TherapeuticsMD, Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    TherapeuticsMD Announces First Quarter 2023 Financial Results
    From TherapeuticsMD, Inc.
    Via Business Wire
    TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
    From TherapeuticsMD, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
    From TherapeuticsMD, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
    From TherapeuticsMD, Inc.
    Via Business Wire
    TherapeuticsMD Announces Third Quarter 2022 Financial Results
    From TherapeuticsMD, Inc.
    Via Business Wire
    TherapeuticsMD Announces Additional $7 Million Private Placement
    From TherapeuticsMD, Inc.
    Via Business Wire
    TherapeuticsMD Announces $7 Million Private Placement
    From TherapeuticsMD, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
    From TherapeuticsMD, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.